# Prevent Breast Cancer

## Details

- **Country:** England & Wales
- **Charity number:** 1109839
- **Other names:** GENESIS BREAST CANCER PREVENTION APPEAL LIMITED, PREVENT BREAST CANCER LIMITED, THE GENESIS APPEAL COMPANY LIMITED, THE GENESIS APPEAL FOR GENE RESEARCH INTO BREAST CANCER
- **Status:** Registered
- **Legal form:** Charitable company
- **Registered:** June 3, 2005
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1109839


## Contact

- **Address:** THE NIGHTINGALE CENTRE, WYTHENSHAWE HOSPITAL, SOUTHMOOR ROAD, MANCHESTER
- **Postcode:** M23 9LT
- **Phone:** 07841357392
- **Email:** nikki@preventbreastcancer.org.uk
- **Website:** www.preventbreastcancer.org.uk



## Activities

**Objects:** The advancement of health by the prevention of breast cancer for the public benefit worldwide but in particular in the United Kingdom by: -                                                      i.    Funding research into the causes, prevention, detection and early diagnosis of breast cancer and that the results of the research are promoted and published for the public benefit;ii. Participating in, facilitating or supporting national and international research and development to overcome health inequalities in all aspects of breast cancer prevention among UK ethnic and cultural groups and to disseminate and share output from such programmes to improve breast cancer outcomes for these communities;                                                    iii.     Informing, raising awareness, so that the public can learn and educate themselves by producing, disseminating and promoting important public health messages about breast cancer risks, symptoms, detection and treatment;                                                   iv.     Supporting and raising awareness of technological and all other scientific, best practice and diagnostic advancements in breast screening including but not, limited to the support for the National Breast Imaging Academy;                                                  v.     Providing pastoral services to support patients and their families affected by breast cancer, including but not limited to patient welcoming, orientation, break out spaces and refreshments at the breast screening unit;                                                      vi.    Advancing all aspects of breast cancer prediction, detection, risk reduction, management, prevention and diagnosis; and                                                    vii.     Advancing such other aspects of breast cancer prevention as medical and technological advances may recognise and develop in the future, as the trustees in their absolute discretion may determine.

**Activities:** To fund ground-breaking research into the prediction and prevention of breast cancer. Our four pillars of research are gene research, improved screening & early diagnosis, preventative drugs and diet & lifestyle. Our overall aim is to make breast cancer a preventable disease for our future generations.

**Area of benefit:** THE UNITED KINGDOM.




## Classification

- **How:** Makes Grants To Organisations, Provides Human Resources, Provides Advocacy/advice/information, Sponsors Or Undertakes Research
- **What:** The Advancement Of Health Or Saving Of Lives
- **Who:** The General Public/mankind



## Areas of operation

- Throughout England And Wales



## Finances

| Period end | Income | Expenditure | Assets | Employees |
|---|---|---|---|---|
| March 31, 2025 | £2169572 | £1544127 | £2313030 | 18 |
| March 31, 2024 | £1472692 | £1594010 | £1669709 | 14 |
| March 31, 2023 | £1448751 | £1143866 | £1728828 | 13 |
| March 31, 2022 | £1130017 | £517683 | £1459093 | 12 |
| March 31, 2021 | £672068 | £438976 | £841453 | 12 |



## Trustees

- **Eamonn O'Neal OBE DL** (Chair) — appointed Feb. 14, 2022
- CHRISTINE LEE-JONES — appointed Nov. 29, 2012
- Diana Harris — appointed April 10, 2014
- Dr MARY WILSON
- Jane Humphris — appointed Nov. 10, 2022
- LESTER BARR
- Mark Sellers — appointed Dec. 1, 2024
- PAM GLASS
- Paul Topham — appointed March 18, 2024
- Sandra Saleh — appointed July 28, 2020
- Tammy Hopla — appointed Jan. 1, 2025